Neuberg D - Search Results

1

Phase I and pharmacokinetic study of bortezomib in combination with idarubicin and cytarabine in patients with acute myelogenous leukemia.

Attar EC, De Angelo DJ, Supko JG, D'Amato F, Zahrieh D, Sirulnik A, Wadleigh M, Ballen KK, McAfee S, Miller KB, Levine J, Galinsky I, Trehu EG, Schenkein D, Neuberg D, Stone RM, Amrein PC. Attar EC, et al. Among authors: d amato f, neuberg d. Clin Cancer Res. 2008 Mar 1;14(5):1446-54. doi: 10.1158/1078-0432.CCR-07-4626. Clin Cancer Res. 2008. PMID: 18316568 Clinical Trial.

2

Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma.

Stone RM, Neuberg D, Soiffer R, Takvorian T, Whelan M, Rabinowe SN, Aster JC, Leavitt P, Mauch P, Freedman AS, et al. Stone RM, et al. Among authors: neuberg d. J Clin Oncol. 1994 Dec;12(12):2535-42. doi: 10.1200/JCO.1994.12.12.2535. J Clin Oncol. 1994. PMID: 7989927

3

Predictive value of clonality assays in patients with non-Hodgkin's lymphoma undergoing autologous bone marrow transplant: a single institution study.

Mach-Pascual S, Legare RD, Lu D, Kroon M, Neuberg D, Tantravahi R, Stone RM, Freedman AS, Nadler LM, Gribben JG, Gilliland DG. Mach-Pascual S, et al. Among authors: neuberg d. Blood. 1998 Jun 15;91(12):4496-503. Blood. 1998. PMID: 9616144 Free article.

4

A Phase II study of adjuvant therapy with anti-B4-blocked ricin after autologous bone marrow transplantation for patients with relapsed B-cell non-Hodgkin's lymphoma.

Grossbard ML, Multani PS, Freedman AS, O'Day S, Gribben JG, Rhuda C, Neuberg D, Nadler LM. Grossbard ML, et al. Among authors: neuberg d. Clin Cancer Res. 1999 Sep;5(9):2392-8. Clin Cancer Res. 1999. PMID: 10499609 Clinical Trial.

5

Outcome in patients with myelodysplastic syndrome after autologous bone marrow transplantation for non-Hodgkin's lymphoma.

Friedberg JW, Neuberg D, Stone RM, Alyea E, Jallow H, LaCasce A, Mauch PM, Gribben JG, Ritz J, Nadler LM, Soiffer RJ, Freedman AS. Friedberg JW, et al. Among authors: neuberg d. J Clin Oncol. 1999 Oct;17(10):3128-35. doi: 10.1200/JCO.1999.17.10.3128. J Clin Oncol. 1999. PMID: 10506609

6

Treatment of patients with recurrent and primary refractory acute myelogenous leukemia using mitoxantrone and intermediate-dose cytarabine: a pharmacologically based regimen.

Sternberg DW, Aird W, Neuberg D, Thompson L, MacNeill K, Amrein P, Shulman LN. Sternberg DW, et al. Among authors: neuberg d. Cancer. 2000 May 1;88(9):2037-41. doi: 10.1002/(sici)1097-0142(20000501)88:9<2037::aid-cncr8>3.0.co;2-k. Cancer. 2000. PMID: 10813714

7

Rituximab and CHOP induction therapy for newly diagnosed mantle-cell lymphoma: molecular complete responses are not predictive of progression-free survival.

Howard OM, Gribben JG, Neuberg DS, Grossbard M, Poor C, Janicek MJ, Shipp MA. Howard OM, et al. J Clin Oncol. 2002 Mar 1;20(5):1288-94. doi: 10.1200/JCO.2002.20.5.1288. J Clin Oncol. 2002. PMID: 11870171 Clinical Trial.

8

CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML).

Kelly LM, Yu JC, Boulton CL, Apatira M, Li J, Sullivan CM, Williams I, Amaral SM, Curley DP, Duclos N, Neuberg D, Scarborough RM, Pandey A, Hollenbach S, Abe K, Lokker NA, Gilliland DG, Giese NA. Kelly LM, et al. Among authors: neuberg d. Cancer Cell. 2002 Jun;1(5):421-32. doi: 10.1016/s1535-6108(02)00070-3. Cancer Cell. 2002. PMID: 12124172 Free article.

9

Proteasome inhibitor PS-341 inhibits human myeloma cell growth in vivo and prolongs survival in a murine model.

LeBlanc R, Catley LP, Hideshima T, Lentzsch S, Mitsiades CS, Mitsiades N, Neuberg D, Goloubeva O, Pien CS, Adams J, Gupta D, Richardson PG, Munshi NC, Anderson KC. LeBlanc R, et al. Among authors: neuberg d. Cancer Res. 2002 Sep 1;62(17):4996-5000. Cancer Res. 2002. PMID: 12208752

10

Quantitative monitoring of BCR/ABL transcript during STI-571 therapy.

Wu CJ, Neuberg D, Chillemi A, McLaughlin S, Hochberg EP, Galinsky I, DeAngelo D, Soiffer RJ, Alyea EP, Capdeville R, Stone RM, Ritz J. Wu CJ, et al. Among authors: neuberg d. Leuk Lymphoma. 2002 Dec;43(12):2281-9. doi: 10.1080/1042819021000039992. Leuk Lymphoma. 2002. PMID: 12613514

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

678 results

Search Page